Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000769993-14-000531
Filing Date
2014-08-14
Accepted
2014-08-14 17:26:43
Documents
1
Period of Report
2014-08-12

Document Format Files

Seq Description Document Type Size
1 ownershipdoc08022014070156.html 4  
1 ownershipdoc08022014070156.xml 4 9295
  Complete submission text file 0000769993-14-000531.txt   10636
Mailing Address C/O GOLDMAN, SACHS & CO. 85 BROAD STREET NEW YORK NY 10004
Business Address
CARELLA THOMAS J. (Reporting) CIK: 0001477767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 141044391

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus